Deerfield, IL (December 4, 2017) – Advanced Clinical, a clinical development organization providing CRO, FSP, Quality & Validation, and Strategic Resourcing services, announced the opening of its new offices in Frankfurt, Germany and Amsterdam, Netherlands. With legal entities established in both Germany and the Netherlands, Advanced Clinical’s new offices will accommodate the growth of global clinical trial operations and additional in-country personnel.

“Since a large percentage of our CRO and FSP businesses include the management of global trials, our customers have driven our expansion into Europe,” said Julie Ross, President of Advanced Clinical. “These new office locations are key to our global progression, and continued investments will enable our teams to better serve the growing demands of global clinical programs. The addition of these two new locations allows Advanced Clinical to more closely serve our current customers while reaching new ones with our differentiated offering.”

Advanced Clinical plans to establish legal entities in five additional countries in 2018 as part of the global expansion strategy. Established in 1994, Advanced Clinical’s North American headquarters in Deerfield, Illinois, has ranked as one of Chicago Tribune’s Top 100 Workplaces for the last eight consecutive years (2010-2017). Advanced Clinical has additional offices in San Francisco, CA; San Diego, CA; Orlando, FL; and Providence, RI.

About Advanced Clinical
Advanced Clinical is a global clinical development organization that provides CRO, FSP, Quality & Validation, and Strategic Resourcing services for biopharmaceutical and medical device organizations. Our mission is to deliver a better clinical experience for our clients. To learn more, visit www.advancedclinical.com.

Contact Information:
Lizzie Evans
Market Development Manager
Advanced Clinical
847-943-2934
eevans@advancedclinical.com

Retour aux actualités

Contactez-nous

Découvrez comment Advanced Clinical peut vous aider à créer une meilleure expérience clinique.

Parlons-en